Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Other Non-Current Liabilities (2021 - 2022)

Edgewise Therapeutics has reported Other Non-Current Liabilities over the past 2 years, most recently at $192000.0 for Q2 2022.

  • Quarterly results put Other Non-Current Liabilities at $192000.0 for Q2 2022, changed N/A from a year ago — trailing twelve months through Jun 2022 was $192000.0 (changed N/A YoY), and the annual figure for FY2021 was $329000.0, changed.
  • Other Non-Current Liabilities reached $192000.0 in Q2 2022 per EWTX's latest filing, up from $187000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $329000.0 in Q4 2021 and bottomed at $187000.0 in Q1 2022.